|
CFC1
MCID: CRD224
MIFTS: 70
|
Cardiofaciocutaneous Syndrome 1 (CFC1)
Categories:
Cardiovascular diseases, Fetal diseases, Genetic diseases, Neuronal diseases, Rare diseases, Skin diseases
|
|
|
|
MalaCards integrated aliases for Cardiofaciocutaneous Syndrome 1:
Characteristics:Orphanet epidemiological data:58
cardiofaciocutaneous syndrome
Inheritance: Autosomal dominant; Prevalence: 1-9/1000000 (Japan); Age of onset: Antenatal,Neonatal; Age of death: any age; OMIM:56
Inheritance:
autosomal dominant
Miscellaneous:
associated with advanced paternal age most cases are sporadic autosomal dominant transmission has been rarely reported phenotypic similarities to noonan syndrome phenotypic similarities to costello syndrome HPO:31
cardiofaciocutaneous syndrome 1:
Inheritance autosomal dominant inheritance Onset and clinical course congenital onset GeneReviews:24
Penetrance Penetrance is complete in cfc syndrome.
Classifications:
MalaCards categories:
Global: Genetic diseases Rare diseases Fetal diseases Anatomical: Neuronal diseases Cardiovascular diseases Skin diseases
ICD10:
32
33
Orphanet: 58
Rare neurological diseases
Rare circulatory system diseases
Rare cardiac malformations
Rare skin diseases
Developmental anomalies during embryogenesis External Ids:
|
|
Genetics Home Reference :
25
Cardiofaciocutaneous syndrome is a disorder that affects many parts of the body, particularly the heart (cardio-), facial features (facio-), and the skin and hair (cutaneous). People with this condition also have delayed development and intellectual disability, usually ranging from moderate to severe.
Heart defects occur in most people with cardiofaciocutaneous syndrome. The heart problems most commonly associated with this condition include malformations of one of the heart valves that impairs blood flow from the heart to the lungs (pulmonic stenosis), a hole between the two upper chambers of the heart (atrial septal defect), and a form of heart disease that enlarges and weakens the heart muscle (hypertrophic cardiomyopathy).
Cardiofaciocutaneous syndrome is also characterized by distinctive facial features. These include a high forehead that narrows at the temples, a short nose, widely spaced eyes (ocular hypertelorism), outside corners of the eyes that point downward (down-slanting palpebral fissures), droopy eyelids (ptosis), a small chin, and low-set ears. Overall, the face is broad and long, and the facial features are sometimes described as "coarse."
Skin abnormalities occur in almost everyone with cardiofaciocutaneous syndrome. Many affected people have dry, rough skin; dark-colored moles (nevi); wrinkled palms and soles; and a skin condition called keratosis pilaris, which causes small bumps to form on the arms, legs, and face. People with cardiofaciocutaneous syndrome also tend to have thin, dry, curly hair and sparse or absent eyelashes and eyebrows.
Infants with cardiofaciocutaneous syndrome typically have weak muscle tone (hypotonia), feeding difficulties, and a failure to grow and gain weight at the normal rate (failure to thrive). Additional features of this disorder in children and adults can include an unusually large head (macrocephaly), short stature, problems with vision, and seizures.
The signs and symptoms of cardiofaciocutaneous syndrome overlap significantly with those of two other genetic conditions, Costello syndrome and Noonan syndrome. The three conditions are distinguished by their genetic cause and specific patterns of signs and symptoms; however, it can be difficult to tell these conditions apart, particularly in infancy. Unlike Costello syndrome, which significantly increases a person's cancer risk, cancer does not appear to be a major feature of cardiofaciocutaneous syndrome.
MalaCards based summary : Cardiofaciocutaneous Syndrome 1, also known as cardiofaciocutaneous syndrome, is related to costello syndrome and heart septal defect. An important gene associated with Cardiofaciocutaneous Syndrome 1 is BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase), and among its related pathways/superpathways are MAPK signaling pathway and Signaling by GPCR. The drugs Fluticasone and Sympathomimetics have been mentioned in the context of this disorder. Affiliated tissues include heart, skin and lung, and related phenotypes are intellectual disability and muscular hypotonia Disease Ontology : 12 A syndrome characterized by unusually sparse, brittle, curly hair, macrocephaly, a prominent forehead and bi-temporal narrowing, intellectual disability, failure to thrive, congenital heart defects, short stature and skin abnormalities, and has material basis in mutation in the BRAF, MAP2K1, MAP2kK2 and KRAS genes. NIH Rare Diseases : 52 Cardiofaciocutaneous (CFC) syndrome is a disorder that affects many parts of the body, particularly the heart, face, skin, and hair. People with this condition also have developmental delay and intellectual disability , usually ranging from moderate to severe. The signs and symptoms of CFC syndrome overlap significantly with those of two other conditions, Costello syndrome and Noonan syndrome . These syndromes belong to a group of related conditions called the RASopathies , which are distinguished by their genetic causes and specific pattern of features. It can sometimes be hard to tell these conditions apart in infancy. CFC syndrome is usually caused by a mutation in the BRAF gene , but can also be due to a mutation in the MAP2K1 , MAP2K2 or KRAS g ene. It is an autosomal dominant condition, but most cases are not inherited , due to a new mutation that occurs for the first time in an affected person. Treatment depends on the symptoms in each person and may include surgery for heart defects. OMIM : 56 Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects, and mental retardation (summary by Niihori et al., 2006). The heart defects include pulmonic stenosis, atrial septal defect, and hypertrophic cardiomyopathy. Some patients have ectodermal abnormalities such as sparse and friable hair, hyperkeratotic skin lesions, and a generalized ichthyosis-like condition. Typical facial characteristics include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. Most cases occur sporadically, but autosomal dominant transmission has been rarely reported (Linden and Price, 2011). Roberts et al. (2006) provided a detailed review of CFC syndrome, including a discussion of the phenotypic overlap of CFC syndrome with Noonan syndrome (NS1; 163950) and Costello syndrome (218040). (115150) KEGG : 36 Cardio-facio-cutaneous (CFC) syndrome is a congenital disorder characterized by short stature, a characteristic face, cardiac defects, developmental delay and mental retardation. Affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial characteristics include high forehead, down-slanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears. CFC can be caused by mutations in BRAF, KRAS, MEK1, and MEK2, encoding components of the RAS-MAPK pathway. UniProtKB/Swiss-Prot : 73 Cardiofaciocutaneous syndrome 1: A multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. Wikipedia : 74 Cardiofaciocutaneous (CFC) syndrome is an extremely rare and serious genetic... more...
GeneReviews:
NBK1186
|
Human phenotypes related to Cardiofaciocutaneous Syndrome 1:58 31 (show top 50) (show all 123)
Symptoms via clinical synopsis from OMIM:56Clinical features from OMIM:115150GenomeRNAi Phenotypes related to Cardiofaciocutaneous Syndrome 1 according to GeneCards Suite gene sharing:26 (show all 40)
MGI Mouse Phenotypes related to Cardiofaciocutaneous Syndrome 1:45 (show all 18)
|
Drugs for Cardiofaciocutaneous Syndrome 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):(show all 19)
Interventional clinical trials:
|
MalaCards organs/tissues related to Cardiofaciocutaneous Syndrome 1:40
Heart,
Skin,
Lung,
Eye,
Thyroid,
Bone,
Brain
|
Articles related to Cardiofaciocutaneous Syndrome 1:(show top 50) (show all 178)
|
Genes related to Cardiofaciocutaneous Syndrome 1 (4 elite genes):(show all 39) - Elite gene
- Cancer Census gene in COSMIC
|
ClinVar genetic disease variations for Cardiofaciocutaneous Syndrome 1:6 (show top 50) (show all 236)
UniProtKB/Swiss-Prot genetic disease variations for Cardiofaciocutaneous Syndrome 1:73 (show all 24)
|
|
Search
GEO
for disease gene expression data for Cardiofaciocutaneous Syndrome 1.
|
Pathways related to Cardiofaciocutaneous Syndrome 1 according to KEGG:36
Pathways related to Cardiofaciocutaneous Syndrome 1 according to GeneCards Suite gene sharing:(show top 50) (show all 207)
|
Cellular components related to Cardiofaciocutaneous Syndrome 1 according to GeneCards Suite gene sharing:
Biological processes related to Cardiofaciocutaneous Syndrome 1 according to GeneCards Suite gene sharing:(show all 38)
Molecular functions related to Cardiofaciocutaneous Syndrome 1 according to GeneCards Suite gene sharing:
|
|